Mandate

Vinge advises Taiyo Nippon Sanso corporation and Matheson Tri-Gas on the acquisition of the swedish part of Praxair’s european industrial gas business

July 10, 2018 M&A

Vinge advises Japanese industrial gas producer Taiyo Nippon Sanso Corporation (TNSC) and its subsidiary Matheson Tri-Gas (MTG) on the acquisition of the Swedish part of Praxair's European industrial gas business.

The transaction expands TNSC's global presence and represents its entry into the European market. The purchase price for Praxair's European industrial gas business amounts to approximately EUR 5 billion.

The transaction is subject to the successful completion of the Praxair and Linde merger and the fulfilment of antitrust conditions. In order to obtain the approval of the European Commission and the U.S. Federal Trade Commission, Linde and Praxair have to sell European and non-European assets. Praxair will continue to operate these businesses until the completion of the merger. The transaction is expected to close in the second half of 2018.

Vinge’s team consists of Matthias Pannier together with associates Karl Klackenberg, Carl Sander and Boris Kotur. 
 

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025